Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blood

Showing results (1391-1400 of 39,482) with videos related to

Pageof 3,949
Sort By:
Blood|November 3, 2022
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapyOliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, et al.
Blood|July 12, 2015
Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserineGary E Gilbert, Valerie A Novakovic, Jialan Shi, et al.
Blood|July 12, 2015
Disease evolution and outcomes in familial AML with germline CEBPA mutationsKiran Tawana, Jun Wang, Aline Renneville, et al.
Blood|July 16, 2015
Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics dataHiroshi Deguchi, Yajnavalka Banerjee, Sunia Trauger, et al.
Blood|July 18, 2015
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killingPatrizia Leone, Simona Berardi, Maria Antonia Frassanito, et al.
Blood|July 18, 2015
In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicityJoanna J Messmann, Tanja Reisser, Frank Leithäuser, et al.
Blood|September 3, 2025
Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemiaHongwei Ren, Natalina Elliott, Bryan Lye, et al.
Blood|June 13, 2015
A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARsAnthony Mato, David L Porter
Blood|September 2, 2025
Nanoromidepsin, a Polymer Nanoparticle of the HDAC Inhibitor, Improves Safety and Efficacy in Models of T-cell LymphomaIpsita Pal, Anuradha Illendula, Andrea Megan Joyner, et al.
Blood|July 22, 2016
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantationAnushruti Sarvaria, Rafet Basar, Rohtesh S Mehta, et al.
Pageof 3,949

Showing results (1391-1400 of 39,482) with videos related to

Sort By:
Pageof 3,949
Blood|November 3, 2022
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapyOliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, et al.
Blood|July 12, 2015
Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserineGary E Gilbert, Valerie A Novakovic, Jialan Shi, et al.
Blood|July 12, 2015
Disease evolution and outcomes in familial AML with germline CEBPA mutationsKiran Tawana, Jun Wang, Aline Renneville, et al.
Blood|July 16, 2015
Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics dataHiroshi Deguchi, Yajnavalka Banerjee, Sunia Trauger, et al.
Blood|July 18, 2015
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killingPatrizia Leone, Simona Berardi, Maria Antonia Frassanito, et al.
Blood|July 18, 2015
In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicityJoanna J Messmann, Tanja Reisser, Frank Leithäuser, et al.
Blood|September 3, 2025
Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemiaHongwei Ren, Natalina Elliott, Bryan Lye, et al.
Blood|June 13, 2015
A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARsAnthony Mato, David L Porter
Blood|September 2, 2025
Nanoromidepsin, a Polymer Nanoparticle of the HDAC Inhibitor, Improves Safety and Efficacy in Models of T-cell LymphomaIpsita Pal, Anuradha Illendula, Andrea Megan Joyner, et al.
Blood|July 22, 2016
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantationAnushruti Sarvaria, Rafet Basar, Rohtesh S Mehta, et al.
Pageof 3,949